genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Drug Discovery
Delivering on a Promise: The Present and Future of Targeted Protein…
Gene Therapy
OXGENE Eyes Further Growth in Cell and Gene Therapy Services after…
Coronavirus
Breathe In: Theravance Reports Positive Phase II Data for JAK Inhibitor
Cancer
The Life Oncolytic, with Stephen Russell
Synthetic Biology
Flush with Cash, Foresite Aims to Live Up to Its Name
News
Antibodies
CRISPR-Cas9 Screening Enables Phenotypic Development of Antibody Drugs
Bioprocessing
FUJIFILM Diosynth Biotechnologies Expands Cell Culture Capacity in Denmark
Bioprocessing
Pharmaron Acquires Bioprocessing Site from AbbVie
Natural Products
Catnip’s Effectiveness as a Natural Mosquito Repellent Linked to Irritant Receptor…
Cancer
Collagen Plays Protective Role during Pancreatic Cancer Development
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
Harvesting Plastic from Plants
Infectious Diseases
SARS-CoV-2 Under Surveillance
Cancer
Immune Cell Profiles Reveal Cancer’s Leading Indicators
Translational Medicine
Animal Models Offer Improved Translatability
A-Lists
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Antibodies
CRISPR-Cas9 Screening Enables Phenotypic Development of Antibody Drugs
Bioprocessing
FUJIFILM Diosynth Biotechnologies Expands Cell Culture Capacity in Denmark
Bioprocessing
Pharmaron Acquires Bioprocessing Site from AbbVie
Cancer
Collagen Plays Protective Role during Pancreatic Cancer Development
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
RNA
Gene Silencing
Gene Silencing
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Gene Silencing
CRISPR System’s Optimized Guides Can Target RNA, Including Coronavirus RNA
Gene Silencing
Silencing Breast Cancer Genes Using Morpholino Embedded DNA-Tile-AuNPs Nanostructures
Gene Silencing
Transposon-Silencing RNA Takes Alternate Route from Nucleus to Kill Zone
Gene Silencing
Blocking Brain Circuit Curbs Fatty Food Cravings When Dieting
Gene Silencing
FDA Approves Alnylam’s Onpattro for Polyneuropathy of hATTR Amyloidosis
Gene Silencing
Compact CRISPR Tool Effectively Targets RNA
Gene Silencing
Self-Assembling Nanoparticles Claimed to Represent Personalized Medicine “Milestone”
Gene Silencing
Unlike CRISPR Knockout and RNAi Knockdown, Trim-Away Depletes Proteins Straightaway
Gene Silencing
Transposons Stir in Germline, but Small RNAs Still Them
Gene Silencing
Gene-Silencing Finding May Lead to Better Understanding of Some Cancers
Gene Silencing
Ticks’ Tricks for Skipping Tick-Borne Sicks
Gene Silencing
MicroRNA Maneuvers Limit Time on Target, Maintain Ace Status
Gene Silencing
Humans Rely on RNAi to Fight the Flu
Gene Silencing
Gene-Silencing RNA Passes from Parent to Offspring
Gene Silencing
Patch Has Tumor Covered … with Drug, Gene, and Light Therapy
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![CasRx (magenta) targeting RNA in the nucleus of human cells (gray). [Salk Institute]](https://www.genengnews.com/wp-content/uploads/2018/08/Mar16_2018_SalkInst_CasRx2311411691-324x160.jpg "Compact CRISPR Tool Effectively Targets RNA")
